Ignite Creation Date:
2025-12-24 @ 7:36 PM
Ignite Modification Date:
2025-12-29 @ 10:43 AM
Study NCT ID:
NCT04969003
Status:
COMPLETED
Last Update Posted:
2022-05-03
First Post:
2021-07-08
Is NOT Gene Therapy:
True
Has Adverse Events:
False
Brief Title:
Reducing Transphobia Among Adolescents Through a Brief Video Intervention
Sponsor:
Yale University
Organization:
Study Overview
Official Title:
Reducing Transphobia Among Adolescents Through a Brief Video Intervention
Status:
COMPLETED
Status Verified Date:
2022-05
Last Known Status:
None
Delayed Posting:
No
If Stopped, Why?:
Not Stopped
Has Expanded Access:
False
If Expanded Access, NCT#:
N/A
Has Expanded Access, NCT# Status:
N/A
Acronym:
None
Brief Summary:
The purposes of this new study are to test among adolescent viewers the utility of brief video-based interventions to:
1. reduce transphobia;
2. reduce depression-related stigma and increase likelihood of treatment-seeking; and
3. examine the role of viewer's sex (male / female / non-binary), race (Black vs non-Black), and sexual orientation (straight vs LGBQ) as independent factors on the outcomes of interest.
1. reduce transphobia;
2. reduce depression-related stigma and increase likelihood of treatment-seeking; and
3. examine the role of viewer's sex (male / female / non-binary), race (Black vs non-Black), and sexual orientation (straight vs LGBQ) as independent factors on the outcomes of interest.
Detailed Description:
Intervention videos will each be of \~100-second duration and feature four underage professionals (ages 16) acting as simulated patients. All videos will focus on an empowered presenter with depression sharing their personal story regarding depression. They will describe how social supports from family, friends, and community, as well as professional help assisted them in overcoming symptoms of the illness, as well as how being transgender may have had an impact on it. The four actors will include two males (one trans, one cis) and tow females (one trans, one cis).
Assessments will occur at baseline and post-intervention, and will include:
1. Demographics (baseline only);
2. Primary outcome:
a. Attitudes toward Transgender Men and Women (ATTMW) scale.
3. Secondary outcome:
1. Transgender attitudes: feelings thermometer, modeled after Norton et al 2013.
2. Depression-related stigma (Depression Stigma Scale \[DSS\]);and
3. Help-seeking (General Help-Seeking Questionnaire \[GHSQ\]).
For each of study we intend to randomly assign \~1,000 individuals aged 14-18 as follows:
Randomized, in equal proportions, and stratified by sex and race, to view one of four \~100-second videos:
1. Transgender male;
2. Cis-gender male);
3. Transgender female;
4. Cis-gender female.
Assessments will occur at baseline and post-intervention, and will include:
1. Demographics (baseline only);
2. Primary outcome:
a. Attitudes toward Transgender Men and Women (ATTMW) scale.
3. Secondary outcome:
1. Transgender attitudes: feelings thermometer, modeled after Norton et al 2013.
2. Depression-related stigma (Depression Stigma Scale \[DSS\]);and
3. Help-seeking (General Help-Seeking Questionnaire \[GHSQ\]).
For each of study we intend to randomly assign \~1,000 individuals aged 14-18 as follows:
Randomized, in equal proportions, and stratified by sex and race, to view one of four \~100-second videos:
1. Transgender male;
2. Cis-gender male);
3. Transgender female;
4. Cis-gender female.
Study Oversight
Has Oversight DMC:
True
Is a FDA Regulated Drug?:
False
Is a FDA Regulated Device?:
False
Is an Unapproved Device?:
None
Is a PPSD?:
None
Is a US Export?:
None
Is an FDA AA801 Violation?: